In addition to the cGAS-STING pathway, ICD, release of DAMPs and cytokines can enhance adjuvanticity, elicit migration of pro-anti-cancer immune subpopulation, decrease immunosuppressive cells, alter TME and tilt immune response to cancer cell killing. The gene discussed is STING1; the disease is cancer.